Plain-English translation of NCT07288801 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing whether taking supplements during pregnancy can prevent preeclampsia — a serious condition involving high blood pressure — from returning in women who had it in a previous pregnancy. About 146 pregnant women will be randomly assigned to either take or receive a placebo (a pill with no active ingredient) until 36 weeks of pregnancy. Researchers will track both groups to see how many women develop preeclampsia again.
Preeclampsia is a dangerous pregnancy complication that can recur in future pregnancies, putting both mother and baby at risk. This study is exploring whether this medication might offer a safe, affordable way to reduce that risk and improve outcomes for women who have experienced it before.
You likely qualify if…
You likely don't qualify if…
If you join, you will be randomly assigned to take either supplements or a placebo pill that looks identical. You will take your assigned pill daily until 36 weeks of pregnancy. You'll visit the clinic every two weeks for blood pressure checks and urine tests to monitor for preeclampsia. If you do develop preeclampsia, you'll receive standard medical care right away, and researchers will track your outcome.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
Pakistan
Post-approval monitoring
Sponsor
Nishtar Medical University
Enrollment target
~146 participants
Started
August 2025
Primary completion
February 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
20 Years – 45 Years
Sex
Female only
Last updated on clinicaltrials.gov in December 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Tehseen A Principal Investigator, MBBS
Nishtar Medical University and Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.